Lyft price target lowered by Jefferies on US rideshare slowdown
proactiveinvestors.com
Want to monitor CRSP?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CRSPCRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.